We are seeking healthy participants as control subjects only, aged between 35-65 years old.
Cognitive function is highly prevalent in Multiple Sclerosis (MS). However, routine clinical assessment rarely includes assessment of cognitive function. This clearly impacts the implementation of effective patient management strategies. To address this, we propose the inclusion of ocular motor (OM) measures of cognition in the clinical assessment of MS patients.
This research will ascertain the profile of measures most useful to possibly (1) aid diagnosis, and (2) measure disease progression. Ultimately, this will lead to the development of a user-friendly, cost-effective, surrogate measure of brain damage and therapeutic effect which would dramatically improve patient management, potentially facilitating earlier identification of symptoms and progression and the prediction of disease course.
Contact: Dr Meaghan Clough
Phone: (03) 9903 0895
Department: Van Cleef/Roet Centre for Nervous Diseases, and Department of Neuroscience
Ethics approval: 8068 Monash University